Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adenoma, Islet Cell (Phase 2)
Astrocytoma (Phase 2)
Brain Neoplasms (Phase 1)
Brain Stem Neoplasms (Phase 2)
Breast Neoplasms (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Colonic Neoplasms (Phase 1)
Ependymoma (Phase 2)
Esophageal Neoplasms (Phase 1)
Gastrointestinal Neoplasms (Phase 2)
Glioblastoma (Phase 2)
Gliosarcoma (Phase 2)
Hepatoblastoma (Phase 2)
Intestinal Neoplasms (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Liver Neoplasms (Phase 2)
Lung Neoplasms (Phase 1)
Lymphoma (Phase 1)
Lymphoproliferative Disorders (Phase 1)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Neoplasms (Phase 2)
Neoplastic Syndromes, Hereditary (Phase 2)
Neuroblastoma (Phase 2)
Oligodendroglioma (Phase 2)
Osteosarcoma (Phase 2)
Pancreatic Neoplasms (Phase 1)
Polycythemia Vera (Phase 2)
Primary Myelofibrosis (Phase 3)
Rectal Neoplasms (Phase 1)
Rhabdomyosarcoma (Phase 2)
Sarcoma, Ewing (Phase 2)
Thrombocythemia, Essential (Phase 2)
Thyroid Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue